|
1
|
Friedenstein AJ, Chailakhjan RK and
Lalykina KS: The development of fibroblast colonies in monolayer
cultures of guinea-pig bone marrow and spleen cells. Cell Tissue
Kinet. 3:393–403. 1970.PubMed/NCBI
|
|
2
|
Caplan AI: Mesenchymal stem cells. J
Orthop Res. 9:641–650. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Frausin S, Viventi S, Falzacappa Verga L,
Quattromani MJ, Leanza G, Tommasini A and Valencic E: Wharton's
jelly derived mesenchymal stromal cells: Biological properties,
induction of neuronal phenotype and current applications in
neurodegeneration research. Acta Histochem. 117:329–338. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iser IC, Bracco PA, Goncalves CE, Zanin
RF, Nardi NB, Lenz G, Battastini AM and Wink MR: Mesenchymal stem
cells from different murine tissues have differential capacity to
metabolize extracellular nucleotides. J Cell Biochem.
115:1673–1682. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jung J, Choi JH, Lee Y, Park JW, Oh IH,
Hwang SG, Kim KS and Kim GJ: Human placenta-derived mesenchymal
stem cells promote hepatic regeneration in CCl4 -injured rat liver
model via increased autophagic mechanism. Stem Cells. 31:1584–1596.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Park M, Kim YH, Woo SY, Lee HJ, Yu Y, Kim
HS, Park YS, Jo I, Park JW, Jung SC, et al: Tonsil-derived
mesenchymal stem cells ameliorate CCl4-induced liver fibrosis in
mice via autophagy activation. Sci Rep. 5:86162015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagamura-Inoue T and He H: Umbilical
cord-derived mesenchymal stem cells: Their advantages and potential
clinical utility. World J Stem Cells. 6:195–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harris DT: Umbilical cord tissue
mesenchymal stem cells: Characterization and clinical applications.
Curr Stem Cell Res Ther. 8:394–399. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li WW, Wei YH, Li H, Lai DM and Lin TN:
Isolation and characterization of a novel strain of mesenchymal
stem cells from mouse umbilical cord: Potential application in
cell-based therapy. PLoS One. 8:e744782013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bongso A and Fong CY: The therapeutic
potential, challenges and future clinical directions of stem cells
from the wharton's jelly of the human umbilical cord. Stem Cell
Rev. 9:226–240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barberini DJ, Freitas NP, Magnoni MS, Maia
L, Listoni AJ, Heckler MC, Sudano MJ, Golim MA, da Cruz
Landim-Alvarenga F and Amorim RM: Equine mesenchymal stem cells
from bone marrow, adipose tissue and umbilical cord:
Immunophenotypic characterization and differentiation potential.
Stem Cell Res Ther. 5:252014. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fink KD, Rossignol J, Crane AT, Davis KK,
Bombard MC, Bavar AM, Clerc S, Lowrance SA, Song C, Lescaudron L
and Dunbar GL: Transplantation of umbilical cord-derived
mesenchymal stem cells into the striata of R6/2 mice: Behavioral
and neuropathological analysis. Stem Cell Res Ther. 4:1302013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mitchell KE, Weiss ML, Mitchell BM, Martin
P, Davis D, Morales L, Helwig B, Beerenstrauch M, Abou-Easa K,
Hildreth T, et al: Matrix cells from wharton's jelly form neurons
and glia. Stem Cells. 21:50–60. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ganta C, Chiyo D, Ayuzawa R, Rachakatla R,
Pyle M, Andrews G, Weiss M, Tamura M and Troyer D: Rat umbilical
cord stem cells completely abolish rat mammary carcinomas with no
evidence of metastasis or recurrence 100 days post-tumor cell
inoculation. Cancer Res. 69:1815–1820. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang J, Gu F, Wang H, Hua B, Hou Y, Shi
S, Lu L and Sun L: Mesenchymal stem cell transplantation for
diffuse alveolar hemorrhage in SLE. Nat Rev Rheumatol. 6:486–489.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lindenmair A, Hatlapatka T, Kollwig G,
Hennerbichler S, Gabriel C, Wolbank S, Redl H and Kasper C:
Mesenchymal stem or stromal cells from amnion and umbilical cord
tissue and their potential for clinical applications. Cells.
1:1061–1088. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li W, Zhang Q, Wang M, Wu H, Mao F, Zhang
B, Ji R, Gao S, Sun Z, Zhu W, et al: Macrophages are involved in
the protective role of human umbilical cord-derived stromal cells
in renal ischemia-reperfusion injury. Stem Cell Res. 10:405–416.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang H, Qiu X, Ni P, Qiu X, Lin X, Wu W,
Xie L, Lin L, Min J, Lai X, et al: Immunological characteristics of
human umbilical cord mesenchymal stem cells and the therapeutic
effects of their transplantion on hyperglycemia in diabetic rats.
Int J Mol Med. 33:263–270. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Ezzelarab MB and Cooper DK: Do
mesenchymal stem cells function across species barriers? Relevance
for xenotransplantation. Xenotransplantation. 19:273–285. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bernardo ME and Fibbe WE: Mesenchymal
stromal cells: Sensors and switchers of inflammation. Cell Stem
Cell. 13:392–402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
DelaRosa O and Lombardo E: Modulation of
adult mesenchymal stem cells activity by toll-like receptors:
Implications on therapeutic potential. Mediators Inflamm.
2010:8656012010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pevsner-Fischer M, Morad V, Cohen-Sfady M,
Rousso-Noori L, Zanin-Zhorov A, Cohen S, Cohen IR and Zipori D:
Toll-like receptors and their ligands control mesenchymal stem cell
functions. Blood. 109:1422–1432. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Waterman RS, Tomchuck SL, Henkle SL and
Betancourt AM: A new mesenchymal stem cell (MSC) paradigm:
Polarization into a pro-inflammatory MSC1 or an immunosuppressive
MSC2 phenotype. PLoS One. 5:e100882010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Waterman RS, Henkle SL and Betancourt AM:
Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor
growth whereas MSC2-treatment promotes tumor growth and metastasis.
PLoS One. 7:e455902012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tomchuck SL, Zwezdaryk KJ, Coffelt SB,
Waterman RS, Danka ES and Scandurro AB: Toll-like receptors on
human mesenchymal stem cells drive their migration and
immunomodulating responses. Stem Cells. 26:99–107. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao X, Liu D, Gong W, Zhao G, Liu L, Yang
L and Hou Y: The toll-like receptor 3 ligand, poly(I:C), improves
immunosuppressive function and therapeutic effect of mesenchymal
stem cells on sepsis via inhibiting miR-143. Stem Cells.
32:521–533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu X, Zhang X, Wang S, Qian H, Zhu W, Cao
H, Wang M, Chen Y and Xu W: Isolation and comparison of mesenchymal
stem-like cells from human gastric cancer and adjacent
non-cancerous tissues. J Cancer Res Clin Oncol. 137:495–504. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qiao C, Xu W, Zhu W, Hu J, Qian H, Yin Q,
Jiang R, Yan Y, Mao F, Yang H, et al: Human mesenchymal stem cells
isolated from the umbilical cord. Cell Biol Int. 32:8–15. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop Dj and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The international society for cellular
therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zeddou M, Relic B and Malaise MG:
Umbilical cord fibroblasts: Could they be considered as mesenchymal
stem cells. World J Stem Cells. 6:367–370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hsieh JY, Fu YS, Chang SJ, Tsuang YH and
Wang HW: Functional module analysis reveals differential osteogenic
and stemness potentials in human mesenchymal stem cells from bone
marrow and Wharton's jelly of umbilical cord. Stem Cells Dev.
19:1895–1910. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hua J, Gong J, Meng H, Xu B, Yao L, Qian
M, He Z, Zou S, Zhou B and Song Z: Comparison of different methods
for the isolation of mesenchymal stem cells from umbilical cord
matrix: Proliferation and multilineage differentiation as compared
to mesenchymal stem cells from umbilical cord blood and bone
marrow. Cell Biol Int. Oct 7–2013.(Epub ahead of print). doi:
10.1002/cbin.10188. PubMed/NCBI
|
|
34
|
Ding DC, Chang YH, Shyu WC and Lin SZ:
Human umbilical cord mesenchymal stem cells: A new era for stem
cell therapy. Cell Transplant. 24:339–347. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang L, Liu D, Pu D, Wang Y, Li L, He Y,
Li Y, Li L, Qiu Z, Zhao S and Li W: The role of toll-like receptor
3 and 4 in regulating the function of mesenchymal stem cells
isolated from umbilical cord. Int J Mol Med. 35:1003–1010. 2015.
View Article : Google Scholar : PubMed/NCBI
|
